Biography
Dr Suwaidan is a UK trained Consultant Medical Oncologist with extensive experience in both medical oncology and cancer research. He completed his specialist training through the NIHR Academic Clinical Fellowship in Leicester, followed by a doctoral research fellowship in London, where he combined clinical practice with translational research in cancer biology and therapeutics.
He specialises in the management of a broad range of cancers, with particular interests in thoracic and gastrointestinal cancers. Dr Suwaidan is committed to delivering personalised, evidence-based care, working closely within multidisciplinary teams to ensure the best possible outcomes for his patients.
Alongside his clinical practice, Dr Suwaidan has a strong research background, with interests in immunotherapy, biomarker development, and novel cancer treatments. He has contributed to a number of clinical trials and peer-reviewed publications.
Dr Suwaidan is also actively involved in medical education, supporting the training and development of medical students and resident doctors.
He is accredited by the Royal College of Physicians and the European Society for Medical Oncology, and is a member of the European Society for Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the UK Association of Cancer Physicians (ACP).
GMC number: 7497529
Publications
Immune Evasion in Pancreatic Ductal Adenocarcinoma: Mechanistic Insights and Emerging Strategies to Reinvigorate Anti-Cancer Immunity, E Matini, E Abouelela, O Ogunbiyi, AA Suwaidan, Immuno 6 (1), 15
180P Real-world outcomes of patients with hepatocellular carcinoma receiving first-line atezolizumab with bevacizumab: A UK Midlands cohort, R Phillips, M Quinlan, AA Suwaidan, K Maru, J Hancock, HEM Daniels, Immuno-Oncology and Technology 28
154eP Real-world systemic treatment patterns and outcomes in patients with hepatocellular carcinoma (HCC): Experience from the UK South East Midlands oncology centre, 2019-2024, AAM Suwaidan, H Abdallah, RM Sylva, YI Owoseni, A Vijay, MA Memon, Annals of Oncology 36, S66
Targeting MUS81 endonuclease to enhance chemo-immunotherapy response in head and neck squamous cell carcinoma, AA Suwaidan, A Pasto, C McCarthy, T Pan, J Deng, L Dolcetti, G Alfano, Cancer Research 84 (6_Supplement), 2040-2040
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control, J Deng, T Pan, Z Liu, C McCarthy, JM Vicencio, L Cao, G Alfano, British journal of cancer 129 (12), 1877-1892
For a full list of publications, visit here - Ali Abdulnabi Suwaidan, MB BCh BAO (RCSI), MRCP (UK), MRes, PhD - Google Scholar